Daniel VITT
12Patents
4h-index
20Co-inventors
60Inventor score
Filing activity: Oct 20, 2000 → Nov 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8207174B2 | Aryloxypropanolamines, methods of preparation therof and use of aryloxypropanolamines as medicaments | Chemistry; Metallurgy | 18 | Active |
| US9951050B2 | Method of inhibiting DYRK1B | Human Necessities | 6 | Active |
| US8354433B2 | Anti-inflammatory agents as virostatic compounds | Emerging Cross-Sectional Technologies | 6 | Active |
| US8653138B2 | Calcium salts of compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | Chemistry; Metallurgy | 4 | Active |
| US11376232B2 | Vidofludimus for use in the treatment or prevention of viral diseases | Chemistry; Metallurgy | 1 | Active |
| US6727100B1 | Method of identifying candidate molecules | Physics | 1 | Expired |
| US11292788B2 | IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation | Chemistry; Metallurgy | 0 | Active |
| US11877994B2 | Treatment of multiple sclerosis comprising DHODH inhibitors | Human Necessities | 0 | Active |
| US12167994B2 | Vidofludimus for use in the treatment or prevention of viral diseases | Chemistry; Metallurgy | 0 | Active |
| US11877995B2 | Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US10633369B2 | Method of inhibiting DYRK1B | Human Necessities | 0 | Active |
| US12037305B2 | Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.